Evidence map›Paper›PMID 32185475›Full record

ArticleEuropean journal of pediatrics2020

Melanocortin 4 receptor (MC4R) gene variants in children and adolescents having familial early-onset obesity: genetic and clinical characteristics.

Ayça Aykut, Samim Özen, Damla Gökşen, Aysun Ata, Hüseyin Onay, Tahir Atik, Şükran Darcan, Ferda Özkinay

Open access · bronzeAbstract read
In one paragraph

Article in European journal of pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Metabolic underpinnings of cancer-related fatigue.American journal of physiology. Endocrinology and metabolism · 2024
    Review
  14. Article
  15. A comprehensive review of genetic causes of obesity.World journal of pediatrics : WJP · 2024
    Review
  16. Liraglutide Treatment in a Morbidly Obese Adolescent with aJournal of clinical research in pediatric endocrinology · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ayça AykutDepartment of Medical Genetics, Ege University School of Medicine, İzmir, Turkey.
Samim ÖzenDepartment of Pediatric Endocrinology, Ege University School of Medicine, İzmir, Turkey. samimozen@gmail.com.
Damla GökşenDepartment of Pediatric Endocrinology, Ege University School of Medicine, İzmir, Turkey.
Aysun AtaDepartment of Pediatric Endocrinology, Ege University School of Medicine, İzmir, Turkey.
Hüseyin OnayDepartment of Medical Genetics, Ege University School of Medicine, İzmir, Turkey.
Tahir AtikDepartment of Pediatric Genetics, Ege University School of Medicine, İzmir, Turkey.
Şükran DarcanDepartment of Pediatric Endocrinology, Ege University School of Medicine, İzmir, Turkey.
Ferda ÖzkinayDepartment of Medical Genetics, Ege University School of Medicine, İzmir, Turkey.
Ege University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanocortin 4 receptor gene plays an important role in food intake, energy balance, and weight control. The autosomal dominantly inherited MC4R variants cause obesity by causing hyperphagia and decreased sense of satiety. Homozygous variants are rarely reported, and they cause earlier/severe obesity. Our objective is to determine the MC4R gene variant frequency in children and adolescents with familial early-onset obesity. One hundred thirty-nine children and adolescents (57 girls/82 boys) whose weight increase started before the age of 5 years and who had early-onset obesity in at least one of their first-degree relatives were included in the study. Obesity is defined as body mass index (BMI) of ≥ 95th percentile, and as extreme obesity is defined if the BMI ≥ 120% of the 95th percentile or ≥ 35 kg/m

Indexed as

Receptor, Melanocortin, Type 4Weight GainAdolescentBody Mass IndexBody WeightChildChild, PreschoolFemaleHumansMaleMutationTurkeyMC4R protein, humanReceptor, Melanocortin, Type 4MC4RMonogenic obesityPediatrics

Identifiers

PMID32185475
PMCPMC7223532
OpenAlexW3011069812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.